natriuretic peptide (Washington University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namenatriuretic peptide (Washington University)
Drug Alias Name64Cu-DOTA-C-ANF4-18 (Washington University)
ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNatriuretic peptide modulators
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington University
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A